Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > University of Virginia Cancer Center and Keystone Nano Announce Start of Clinical Testing of Ceramide Nanoliposome for Treatment of Solid Tumors

Abstract:
University of Virginia Cancer Center and Keystone Nano, Inc. announce that clinical testing has been initiated at UVA on a new potential cancer therapy. The study is a Phase I clinical trial to assess Ceramide NanoLiposome in the treatment of solid tumors.

University of Virginia Cancer Center and Keystone Nano Announce Start of Clinical Testing of Ceramide Nanoliposome for Treatment of Solid Tumors

Charlottesville, VA and State College, PA | Posted on August 28th, 2017

Dr. Mark Kester, Keystone Nano’s Chief Medical Officer, Director of UVA’s NanoSTAR program and the original developer of Ceramide NanoLiposome, remarked: “We are excited to investigate the effectiveness of this potential therapy in patients with solid tumors.” Mr. Jeff Davidson, Keystone Nano’s CEO remarked: “Our company is pleased to be working with the University of Virginia Cancer Center and look forward to the testing of this new therapy.”
Ceramide is a biologically active lipid that is being examined as a potential treatment for liver cancer, as well as in breast cancer, leukemia and pancreatic cancer. Ceramide NanoLiposome seeks to kill cancer cells while leaving normal cells alone, providing treatment without undue toxicity.

The Phase I portion of the trial will recruit patients with solid tumors to examine dosing and safety. The Phase II component of the trial is expected to focus on Liver Cancer, which kills approximately 27,000 people in the United States and 700,000 worldwide each year. There is currently no effective therapy for this disease. Keystone Nano was recently awarded orphan drug status for the treatment of liver cancer with ceramides in the United States.

####

About Keystone Nano
Based in State College KN is working at the interface between nanotechnology and medicine. In addition to developing Ceramide NanoLiposome, the company is working on additional products using NanoJackets for RNA delivery.

For more information, please click here

Contacts:
eff Sirianni
Managing Member
Monarch Solutions, LLC
Ashburn, VA 20147
Mobile: (703) 728.6837
www.Monarchsls.com

Copyright © Keystone Nano

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Cancer

Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018

News and information

Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018

New qubit now works without breaks: A universal design for superconducting qubits has been created April 19th, 2018

Observing biological nanotransporters: Chemistry April 19th, 2018

Salt boosts creation of 2-D materials: Rice University scientists show how salt lowers reaction temperatures to make novel materials April 18th, 2018

Govt.-Legislation/Regulation/Funding/Policy

Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018

Salt boosts creation of 2-D materials: Rice University scientists show how salt lowers reaction temperatures to make novel materials April 18th, 2018

Quantum shift shows itself in coupled light and matter: Rice University scientists corral, quantify subtle movement in condensed matter system April 16th, 2018

When superconductivity disappears in the core of a quantum tube: By replacing the electrons with ultra-cold atoms, a group of physicists has created a perfectly clean material, unveiling new states of matter at the quantum level April 16th, 2018

Nanomedicine

Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018

Observing biological nanotransporters: Chemistry April 19th, 2018

Nanobiotix Shows NBTXR3 Nanoparticles Can Stoke Anti-Tumor Immune Response April 17th, 2018

Tiny nanomachine successfully completes test drive: Researchers at the University of Bonn and the research institute Caesar build a one-wheeled vehicle out of DNA rings April 11th, 2018

Announcements

Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018

New qubit now works without breaks: A universal design for superconducting qubits has been created April 19th, 2018

Observing biological nanotransporters: Chemistry April 19th, 2018

Salt boosts creation of 2-D materials: Rice University scientists show how salt lowers reaction temperatures to make novel materials April 18th, 2018

Nanobiotechnology

Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018

Observing biological nanotransporters: Chemistry April 19th, 2018

Nanobiotix Shows NBTXR3 Nanoparticles Can Stoke Anti-Tumor Immune Response April 17th, 2018

Tiny nanomachine successfully completes test drive: Researchers at the University of Bonn and the research institute Caesar build a one-wheeled vehicle out of DNA rings April 11th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project